JMP Securities Forecasts Strong Price Appreciation for Enanta Pharmaceuticals (NASDAQ:ENTA) Stock
Enanta Pharmaceuticals (NASDAQ:ENTA – Free Report) had its price target increased by JMP Securities from $23.00 to $24.00 in a report released on Tuesday,Benzinga reports. They currently have a market outperform rating on the biotechnology company’s stock. A number of other equities analysts have also recently weighed in on the stock. Wall Street Zen raised […]
Enanta Pharmaceuticals (NASDAQ:ENTA – Free Report) had its price target increased by JMP Securities from $23.00 to $24.00 in a report released on Tuesday,Benzinga reports. They currently have a market outperform rating on the biotechnology company’s stock. A number of other equities analysts have also recently weighed in on the stock. Wall Street Zen raised […]
